EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation

Byounghwi Ko, Younhee Park iD, Sung Min Kim, Young Jin Kim iD, Hee Byung Koh, Hyung Woo Kim iD, Honglin Piao, Virithy Lon, Minsun Jung, Hyun Jeong Kim, Juhan Lee, Kyu Ha Huh und 6 weitere

American Journal of Nephrology · 06.11.2026

DOI: 10.1159/ajn/ablag034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, online erschienen am 06.11.2026. Verfasst von Byounghwi Ko und 17 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antibody-mediated rejection (ABMR) remains a leading cause of late kidney allograft loss. Recently, microvascular inflammation in kidney biopsy without detectable donor-specific antibodies (DSA)—termed DSA-negative ABMR (DSAneg ABMR)—is increasingly recognized.

Methods

We used the nationwide Korean Transplantation Registry (KOTRY) to compare outcomes among biopsy-proven DSA-positive ABMR (DSApos ABMR), DSAneg ABMR, and T-cell–mediated rejection (TCMR). From 10,391 kidney transplant recipients, 740 patients met inclusion criteria (DSAneg ABMR 90; DSApos ABMR 124; TCMR 526). The primary outcome was kidney graft failure. Cause-specific competing risk models were applied. To elucidate mechanisms of DSAneg ABMR, we integrated KOTRY with an in-depth single-center data, enrolling 56 patients for serologic, genetic, and pathologic investigations using stored biospecimens.

Results

Over 2,610.1 person-years (median follow-up 3.10 years), the primary outcome occurred in 93 (12.6%) patients (14 in DSAneg ABMR, 15 in DSApos ABMR, and 64 in TCMR; incidence 3.56/100 person-years). Versus DSAneg ABMR, fully adjusted hazard ratios (HRs) for the kidney graft failure were 0.78 (95% CI, 0.36–1.69; P=0.52) for DSApos ABMR and 0.64 (0.35–1.18; P=0.15) for TCMR. In the etiologic cohort (n=56), frequent findings included MIC-A and MIC-B gene mismatches (16/19 [84.2%] and 15/19 [78.9%]), SIRPα B-to-A incompatibility (7/19 [36.8%]), kidney-relevant autoantibodies (21/52 [40.4%]), and missing self for NK cells (9/18 [50.0%]). Late-appearing DSAs, MIC-A mismatch, and missing self were associated with worse graft outcomes. While overall Banff scores were comparable between the ABMR groups, the DSAneg group exhibited higher tubulitis and lower microvascular inflammation scores.

Conclusion

Both DSApos ABMR and DSAneg ABMR confer higher risks of adverse outcomes than TCMR in a Korean national cohort. DSAneg ABMR is etiologically heterogeneous with different prognosis. Further prospective studies with systematic biospecimen collection are warranted.

Autor:innen und Institutionen

ORCID-Profile: Younhee Park, Young Jin Kim, Hyung Woo Kim, Jin Sug Kim, Jaeseok Yang

Zitieren

APA

Ko, B., Park, Y., Kim, S. M., Kim, Y. J., Koh, H. B., Kim, H. W., Piao, H., Lon, V., Jung, M., Kim, H. J., Lee, J., Huh, K. H., Seok Kim, B., Kim, M. S., Kim, J. S., Han, S., Kwon, Y. J., & Yang, J. (2026). Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation. American Journal of Nephrology. https://doi.org/10.1159/ajn/ablag034

Vancouver

Ko B, Park Y, Kim SM, Kim YJ, Koh HB, Kim HW, et al. Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation. American Journal of Nephrology. 2026. doi:10.1159/ajn/ablag034

BibTeX
@article{Ko2026,
  author = {Ko, Byounghwi and Park, Younhee and Kim, Sung Min and Kim, Young Jin and Koh, Hee Byung and Kim, Hyung Woo and Piao, Honglin and Lon, Virithy and Jung, Minsun and Kim, Hyun Jeong and Lee, Juhan and Huh, Kyu Ha and Seok Kim, Beom and Kim, Myoung Soo and Kim, Jin Sug and Han, Seungyeup and Kwon, Young Joo and Yang, Jaeseok},
  title = {Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation},
  journal = {American Journal of Nephrology},
  year = {2026},
  doi = {10.1159/ajn/ablag034}
}
Kostenlos starten →